Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month ...
Expert Outlook: DexCom Through The Eyes Of 11 Analysts
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.91, ...
Dexcom’s Growth Potential and Strategic Catalysts Justify Buy Rating and New Price Target
In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...
Dexcom (DXCM) Receives a Buy from Piper Sandler
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...
The Motley Fool28d
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Being insulin-treated is one of the requirements for typical CGM devices like DexCom's G6, and not all of those with type 2 diabetes meet this condition. So DexCom's patient population is ...
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin ...